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Background:  Evidence is growing that renal function is a major predictor of mortality in patients after TAVI. The aim of this study is to determine 
the influence of peri-procedural acute kidney injury (AKI) on prognosis after transcatheter aortic valve implantation (TAVI).
Methods:  TAVI was performed with the 18F-CoreValve™ prosthesis via transfemoral access in 92 consecutive patients with a mean age of 
80.7±6.3 years (STS mortality score 9.4±7.1%, logistic EuroSCORE 30.0±17.5%). 6 patients on chronic dialysis were excluded from this analysis.
Results:  Overall procedural success rate was 98% with one periprocedural death. 30-day mortality was 8.7%, 1-year mortality was 28.3%. AKI 
occurred in 23/86 patients: 15 patients (58%) with AKI died during follow-up. The incidence of AKI was related to peripheral arterial disease (61 
vs. 39%; P=0.04), the occurrence of a systemic inflammatory response syndrome (65 vs. 21%, P<0.001), and to post-procedural, paraprosthetic 
regurgitation ≥2+ (35 vs. 8%; P=0.02). Impaired renal function at baseline reflected by serum creatinine ≥1.58 mg/dL (HR 2.3, 95% CI: 1.1-5.3; 
P=0.04) and the occurrence of AKI (HR 6.6, 95% CI: 2.9-15.2, P<0.001) which was not related to the amount of contrast dye were strong predictors 
of 1-year mortality after TAVI.
Conlusions: The occurrence of peri-procedural AKI - independent whether renal function returns to baseline or not - is the strongest independent 
predictor of 30-day and 1-year mortality after TAVI. 
